Short Interest in Terumo Corp. (OTCMKTS:TRUMY) Declines By 54.4%

Terumo Corp. (OTCMKTS:TRUMY) was the target of a large drop in short interest during the month of May. As of May 15th, there was short interest totaling 14,067 shares, a drop of 54.4% from the April 30th total of 30,823 shares. Based on an average trading volume of 679,301 shares, the days-to-cover ratio is presently 0.0 days. Currently, 0.0% of the company’s shares are sold short.

Analysts Set New Price Targets

TRUMY has been the topic of several recent research reports. Nomura upgraded Terumo to a “hold” rating in a research report on Tuesday, February 24th. Zacks Research raised shares of Terumo to a “hold” rating in a research report on Thursday, April 9th. Two equities research analysts have rated the stock with a Hold rating, According to MarketBeat, Terumo has an average rating of “Hold”.

Terumo Stock Down 2.7%

Terumo stock traded down $0.41 during trading hours on Monday, hitting $14.63. 127,984 shares of the stock traded hands, compared to its average volume of 259,450. The firm’s 50-day moving average price is $13.45 and its two-hundred day moving average price is $13.88. The company has a current ratio of 1.51, a quick ratio of 0.89 and a debt-to-equity ratio of 0.07. The company has a market cap of $21.58 billion, a PE ratio of 23.98 and a beta of 0.62. Terumo has a one year low of $12.08 and a one year high of $19.60.

Terumo (OTCMKTS:TRUMY) last announced its quarterly earnings data on Friday, May 15th. The company reported $0.11 EPS for the quarter, meeting the consensus estimate of $0.11. Terumo had a return on equity of 9.35% and a net margin of 12.09%.The business had revenue of $1.90 billion during the quarter, compared to analyst estimates of $1.84 billion. On average, research analysts forecast that Terumo will post 0.63 EPS for the current year.

About Terumo

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.